Age, Biography and Wiki

Akira Endo (biochemist) was born on 14 November, 1933 in day Yurihonjō, Akita). Discover Akira Endo (biochemist)'s Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is He in this year and how He spends money? Also learn how He earned most of networth at the age of 90 years old?

Popular As N/A
Occupation N/A
Age 91 years old
Zodiac Sign Scorpio
Born 14 November, 1933
Birthday 14 November
Birthplace Higashiyuri (present-day Yurihonjō, Akita)
Nationality Japan

We recommend you to check the complete list of Famous People born on 14 November. He is a member of famous with the age 91 years old group.

Akira Endo (biochemist) Height, Weight & Measurements

At 91 years old, Akira Endo (biochemist) height not available right now. We will update Akira Endo (biochemist)'s Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.

Physical Status
Height Not Available
Weight Not Available
Body Measurements Not Available
Eye Color Not Available
Hair Color Not Available

Dating & Relationship status

He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.

Family
Parents Not Available
Wife Not Available
Sibling Not Available
Children Not Available

Akira Endo (biochemist) Net Worth

His net worth has been growing significantly in 2022-2023. So, how much is Akira Endo (biochemist) worth at the age of 91 years old? Akira Endo (biochemist)’s income source is mostly from being a successful . He is from Japan. We have estimated Akira Endo (biochemist)'s net worth , money, salary, income, and assets.

Net Worth in 2023 $1 Million - $5 Million
Salary in 2023 Under Review
Net Worth in 2022 Pending
Salary in 2022 Under Review
House Not Available
Cars Not Available
Source of Income

Akira Endo (biochemist) Social Network

Instagram
Linkedin
Twitter
Facebook
Wikipedia
Imdb

Timeline

2006

He received the Japan Prize in 2006, the Lasker-DeBakey Clinical Medical Research Award in 2008, the Canada Gairdner International Award in 2017.

1986

In the late 70s Endo moved back to Tokyo and was an associate professor and later a full professor (1986-) at the Tokyo University of Agriculture and Technology between 1979 and 1997. After his official retirement he became the president of Biopharm Research Laboratories.

1980

Endo studied 6,000 compounds, of which three extrolites from Penicillium citrinum mold isolated from a rice sample collected at a grain shop in Kyoto showed an effect. Findings from clinical studies were only reported in 1980.

1970

His most important work in the 1970s was on fungal extrolites and their influence on cholesterol synthesis. He hypothesised that fungi used chemicals to ward off parasitic organisms by inhibiting cholesterol synthesis. The cell membranes of fungi contain ergosterol in place of cholesterol, allowing them to produce compounds that inhibit cholesterol. In 1971 he found a culture broth with citrinin had potent inhibitory activity against HMG-CoA reductase and lowered serum cholesterol levels in rats, but research was suspended because of renal toxicity.

1957

Endo was born on a farm in Northern Japan and had an interest in fungi already at a young age, being an admirer of Alexander Fleming. He obtained a BA at Tohoku University (Faculty of Agriculture) in Sendai in 1957 and a PhD in biochemistry at the same university in 1966.

From 1957 to 1978 he worked as a research fellow at chemical company Sankyo Co.; initially he worked on fungal enzymes for processing fruit juice. Successful discoveries in this field gained him the credit to move to New York City in 1966, and spend two years at the Albert Einstein College of Medicine as a research associate working on cholesterol.

1933

Akira Endo (遠藤 章, Endō Akira, born 14 November 1933) is a Japanese biochemist whose research into the relationship between fungi and cholesterol biosynthesis led to the development of statin drugs, which are some of the best-selling pharmaceuticals in history.